SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-018327
Filing Date
2023-03-14
Accepted
2023-03-14 08:30:50
Documents
1
Period of Report
2023-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5820
  Complete submission text file 0001209191-23-018327.txt   7309
Mailing Address C/O ORCHARD THERAPEUTICS 101 SEAPORT BOULEVARD, 7TH FLOOR BOSTON MA 02210
Business Address
THOMAS FRANK E (Reporting) CIK: 0001242616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38722 | Film No.: 23729272

Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Issuer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)